Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation

Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation

(1) Background: Heart failure (HF) is the final stage of multiple cardiac diseases, which have now become a severe public health problem worldwide. β-Adrenergic receptor (β-AR) overactivation is a major pathological factor associated with multiple cardiac diseases and mediates cardiac fibrosis and i...

Full description

Bibliographic Details
Main Authors: Wenqi Li, Shuwen Zhu, Jing Liu, Zhigang Liu, Honggang Zhou, Qianyi Zhang, Yue Yang, Li Chen, Xiaowei Guo, Tiantian Zhang, Lingxin Meng, Dan Chai, Guodong Tang, Xiaohe Li, Cheng Yang
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Molecules
Subjects:
heart failure
β-adrenergic receptor
cardiac fibrosis
cardiac inflammation
Bruton’s tyrosine kinase
Zanubrutinib
Online Access:https://www.mdpi.com/1420-3049/28/16/6035

Internet

https://www.mdpi.com/1420-3049/28/16/6035

Similar Items